MEDXF - Medexus Pharmaceuticals Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/03/2022
31/03/2021
31/03/2020
Assets
Current assets
Cash
Cash and cash equivalents
10,018
18,704
5,235
Total cash
10,018
18,704
5,235
Net receivables
13,391
18,395
14,744
Inventory
21,351
14,667
14,088
Other current assets
1,280
1,665
1,413
Total current assets
49,111
58,571
40,044
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
2,089
1,865
1,717
Accumulated depreciation
-868
-1,070
-617.6844
Net property, plant and equipment
1,221
795
1,099
Goodwill
10,686
10,653
10,061
Intangible assets
76,565
76,362
69,487
Other long-term assets
1,642
2,132
2,120
Total non-current assets
90,114
89,942
82,767
Total assets
139,225
148,513
122,811
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
15,046
10,569
10,195
Accounts payable
12,046
14,855
8,906
Taxes payable
27
514
680.44
Accrued liabilities
17,128
12,575
13,287
Other current liabilities
2,635
-
-
Total current liabilities
48,108
39,937
34,171
Non-current liabilities
Long-term debt
39,816
34,303
28,616
Deferred tax liabilities
1,521
2,645
6,484
Total non-current liabilities
73,325
90,558
64,360
Total liabilities
121,433
130,495
98,531
Stockholders' equity
Common stock
68,686
66,688
42,186
Retained earnings
-65,249
-62,370
-28,040
Accumulated other comprehensive income
3,971
4,203
3,506
Total stockholders' equity
17,792
18,018
24,281
Total liabilities and stockholders' equity
139,225
148,513
122,811